Metronidazol Stada (Metronidazole)

Metronidazole enters susceptible microorganisms and is reduced in low‑oxygen environments. The reduction creates reactive nitro radicals that damage DNA, inhibit nucleic acid synthesis, and disrupt protein production, leading to microbial cell death. This selective activation explains its effectiveness against anaerobic bacteria and certain protozoa.

The dosage of Metronidazol Stada is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and treatment guidelines. Patients should follow the exact regimen provided by their healthcare professional and not adjust the dose on their own.

Safety data for metronidazole during pregnancy are limited, and the drug should only be used when clearly needed and after risk‑benefit assessment by a qualified practitioner. Limited information is available for breastfeeding; however, small amounts may be excreted in milk, so a healthcare provider should be consulted before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Metronidazol Stada. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Metronidazol Stada offers a broad spectrum against anaerobic bacteria and protozoa, often providing a single‑agent option where combination therapy might be required with other antibiotics. Compared with macrolides or quinolones, metronidazole has a distinct mechanism targeting low‑oxygen organisms, making it the preferred choice for conditions like bacterial vaginosis and trichomoniasis.

Metronidazol Stada should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Metronidazol Stada is administered orally. The tablet (or other oral dosage form) should be swallowed with a full glass of water, preferably with food to reduce gastrointestinal upset, unless the prescribing information advises otherwise.

Serious adverse reactions can include peripheral neuropathy, which may be irreversible, seizures, severe allergic responses such as anaphylaxis, and hepatotoxicity manifested by elevated liver enzymes or jaundice. Patients should seek immediate medical attention if they experience numbness, convulsions, rash with swelling, or signs of liver dysfunction.

Metronidazol Stada is contraindicated in individuals with a known hypersensitivity to metronidazole or other nitroimidazole compounds. Caution is also advised for patients with severe hepatic impairment, known central nervous system disorders, or those who are currently consuming alcohol due to the risk of a disulfiram‑like reaction.